Feedback (GB:FDBK) has released an update.
Feedback plc, a specialist in clinical infrastructure, has announced a name change for its Nominated Adviser and Broker to Panmure Liberum Limited following a merger. The company focuses on improving clinical decision-making through products like Bleepa® and CareLocker®, aiming to make patient data more accessible and foster collaboration among clinicians. Feedback plc is exploring growth opportunities in various markets and expects its SaaS model to enhance revenue visibility as it expands its customer base.
For further insights into GB:FDBK stock, check out TipRanks’ Stock Analysis page.
